Exploring the Stereochemistry of CXCR4-Peptide Recognition and Inhibiting HIV-1 Entry with d-Peptides Derived from Chemokines
Naiming Zhou(Zhejiang University), Ziwei Huang(Nanjing University of Chinese Medicine), Jiansong Luo(Friedrich Schiller University Jena), Joseph Sodroski(Harvard University), Mark J. Cayabyab(Harvard University), James J. Pesavento(Saint Mary's College of California), Dongxiang Liu(Thomas Jefferson University), Xiaobing Han(Thomas Jefferson University), Jing An(SUNY Upstate Medical University), Youli Wang(University of Illinois Urbana-Champaign), Hideko Kaji(Thomas Jefferson University), Zhaowen Luo(Thomas Jefferson University), Xuejun Fan(Thomas Jefferson University), Megumi Hiraoka(Thomas Jefferson University), Chang‐Zhi Dong(University of Illinois Urbana-Champaign)
Cited by 117
Related Papers
How many human proteoforms are there?
|Nature Chemical Biology|2018|942
Inhibition of CXCR4 with the novel RCP168 peptide overcomes stroma-mediated chemoresistance in chronic and acute leukemias
|Molecular Cancer Therapeutics|2006|186
Structural and Functional Characterization of Human CXCR4 as a Chemokine Receptor and HIV-1 Co-receptor by Mutagenesis and Molecular Modeling Studies
|Journal of Biological Chemistry|2001|138
Bio-template synthesis of Mo-doped polymer carbon nitride for photocatalytic hydrogen evolution
|Applied Catalysis B: Environmental|2019|133
Response Efficacy of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-Analysis
|Frontiers in Oncology|2021|125